PARANOVA CHOSE ORIOLA AS ITS DISTRIBUTION PARTNER

The newly signed long-term cooperation agreement covers not only warehousing and distribution services, but also other value added services related to pharmaceutical marketing.

 

"Efficient first-class distribution partnership is an increasingly important competitive factor in our business environment characterised by rapid tempos. By relying on the modern and user-friendly valued added services provided by our partner, we can intensify the use of our own marketing resources, and to focus, for example, on the management of the pharmacy channel, Managing Director Tita Sirén of Paranova Oy comments the new partnership.

 

"This cooperation agreement means a considerable strengthening of our position in pharmaceutical distribution, and we interpret it as a clear sign of appreciation shown for our persistent work to develop the quality of our operating processes and services. Paranova is one of the fastest growing companies in the pharmaceutical market", President Risto Kanerva of Oriola points out.

 

Focusing on the imports and marketing of parallel products, Paranova Oy is the Finnish subsidiary of the Danish company Paranova A/S.  Its current net sales are almost 27 million Euros, with a growth rate that exceeds the sector average. Alternova Oy concentrates on the imports and marketing of generic medicines.

 

Oriola is a marketer and wholesaler of healthcare and research products and equipment, as well as a leading pharmaceutical distributor. Oriola's main markets are Finland, the Baltic countries, Sweden, Denmark and Russia. Oriola's operations comprise pharmaceutical distribution, pharmacy and retail sales, dental care as well as healthcare and research. Our product offer includes almost 66,000 articles and comprises all areas of healthcare and medical care.

Pharmaceutical distribution and wholesales accounted for 87% or 1,008 million Euros, of the 2004 net sales while the share of healthcare equipment and supplies was 13%. Oriola accounts for over 40% of the Finnish pharmaceutical distribution market. International operations accounted for 5% of the whole. Oriola is the trusted cooperation partner of the world's leading pharmaceutical producers and manufacturers of healthcare equipment and supplies.

Further information:

Oriola; President Risto Kanerva, tel. +358 50 429 2765

Paranova Oy; Managing Director Tita Sirén, tel. +358 40 511 7481

 

Orion Corporation Corporate Communications:

Communications Manager Tuula Laitinen, tel. +358 50 429 2136

 

Orion Corporation

Corporate Communications

P.O. Box 65, FI-02101 Espoo, Finland

www.orion.fi